GregoryJTraceyMD

Family Medicine • Hoboken, NJ

Physician

Join to view full profile

Dr. Tracey is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Tracey's full profile

Already have an account?

Office
79 Hudson St Ste 500
Hoboken, NJ 07030
Phone+1 201-653-7450

Education & Training

CarePoint Health/New York Medical College (Hoboken)Residency, Family Medicine, 1994 - 1997
Ross University School of MedicineClass of 1990

Certifications & Licensure

NJ State Medical License 1997 - 2025

Clinical Trials

Safety, Tolerability, and Pharmacokinetics (PK) of CTP-499 Start of enrollment: 2011 Mar 01
Completed
Phase 1
Phase 1 Single Ascending Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of KBP-5074 Start of enrollment: 2014 Jun 01
Completed
Phase 1
MAD Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PB-119 to Subjects With T2DM Start of enrollment: 2015 Nov 24
Completed
Phase 1
A Study of AZD4205 in Healthy Adult Subjects Start of enrollment: 2018 Nov 12
Completed
Phase 1
Drug Interaction Study Between Dorzagliatin and Sitagliptin Start of enrollment: 2019 Jan 31
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

7 citations
A phase I open-label clinical trial to study drug-drug interactions of Dorzagliatin and Sitagliptin in patients with type 2 diabetes and obesity.
Li Chen, Jiayi Zhang, Yu Sun, Yu Zhao, Xiang Liu
Nature Communications. 2023-03-14